Inhibition of SHP2 enhances the effects of selective receptor tyrosine kinase inhibitors in untreated preclinical models of RET-mutated thyroid cancer.
Wen-Jun Xie
Mengran Tian
Weike Ma
Ying Sun
Lin-Fei Hu
Yu-Ting Zeng
Xing Chen
Xian-Hui Ruan
Xiang-Qian Zheng
Ming Gao
Medicine